Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2026-03-03 @ 6:05 PM
Study NCT ID:
NCT06961760
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2025-11-21
First Post:
2025-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program for CT1812 (Zervimesine)
Sponsor:
Cognition Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
COG1202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None